The Synthego Eclipse Pro is revolutionizing the world of CRISPR genome editing with its advanced design and user-friendly features. It provides an efficient and streamlined protocol for researchers, allowing for precise gene modifications. What sets it apart is its integration of cutting-edge technology that enhances targeting accuracy and minimizes off-target effects. This makes it a preferred choice for scientists looking for reliable results in gene editing.
5000-6000$
The Illumina NovaSeq X Series represents a significant advancement in high-throughput sequencing technology, allowing for rapid and cost-effective genomic analysis. Its unparalleled scalability, with the ability to sequence up to 6 terabases in a single run, makes it ideal for large-scale genome projects. The system also features enhanced flexibility and a streamlined workflow, enabling researchers to optimize their throughput according to their specific needs. This combination of speed, efficiency, and adaptability positions the NovaSeq X Series as a leader in the next-generation sequencing market.
100000-150000$
Twist Bioscience Biofoundry revolutionizes DNA synthesis with its innovative, high-throughput technology. This platform allows for rapid and cost-effective gene assembly, distinguishing itself from competitors in the market. With a focus on precision and scalability, it supports diverse applications in synthetic biology and biotechnology. Its automated workflows enable seamless integration into research and production processes, making it a top choice for researchers and businesses alike.
50000-100000$
BioClone Elite is a premium cloning solution that offers exceptional reliability and efficiency for researchers and professionals in molecular biology. Its unique formulation promotes rapid root development and enhanced vigor, making it stand out among competitors. Designed to maximize cloning success rates, BioClone Elite provides a user-friendly experience with clear protocols. Researchers trust BioClone Elite for its consistent performance and superior results in various applications.
The PacBio Sequel IV System leverages advanced SMRT (Single Molecule, Real-Time) sequencing technology to deliver highly accurate long reads, making it a go-to choice for complex genomic studies. Its high throughput and excellent data quality facilitate the comprehensive understanding of genomic structures, including haplotypes and epigenetic modifications. The Sequel IV System offers rapid run times and straightforward data analysis, significantly enhancing productivity in genomics research. This platform is distinguished by its unmatched performance in resolving challenging genomic regions.
150000-250000$